StockData
Immatics N.V. logo

Immatics N.V. (IMTX) stock

IMTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 1/30
$6.29+0.12 (+1.94%)

Close on Nov 17, 2026Market cap $843.31MP/E –Yield –

Immatics cash

Cash and short-term investments held at the end of each period.

Immatics's cash was €232.46M at Jun 30, 2026. For fiscal 2025 it was €345.92M, up 46.1% from the year before. The highest annual figure on record is €345.92M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025€345.92M+46.1%
FY2024Dec 31, 2024€236.75M+8.4%
FY2023Dec 31, 2023€218.47M+47.1%
FY2022Dec 31, 2022€148.52M+11.7%
FY2021Dec 31, 2021€132.99M-35.9%
FY2020Dec 31, 2020€207.53M+100.8%
FY2019Dec 31, 2019€103.35M+162.5%
FY2018Dec 31, 2018€39.37M+367.8%
FY2017Dec 31, 2017€8.42M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026€232.46M+22.9%
Q4 FY2025Dec 31, 2025€345.92M+118.7%
Q2 FY2025Jun 30, 2025€256.64M+110.2%
Q4 FY2024Dec 31, 2024€236.75M+8.4%
Q3 FY2024Sep 30, 2024€189.20M+45.1%
Q2 FY2024Jun 30, 2024€158.14M+6.5%
Q1 FY2024Mar 31, 2024€122.09M-53.9%
Q4 FY2023Dec 31, 2023€218.47M+64.3%
Q2 FY2023Jun 30, 2023€130.41M-18.5%
Q4 FY2022Dec 31, 2022€148.52M-28.4%
Q2 FY2022Jun 30, 2022€265.13M+208.1%
Q4 FY2021Dec 31, 2021€132.99M+28.7%
Q2 FY2021Jun 30, 2021€160.09M+306.7%
Q4 FY2020Dec 31, 2020€207.53M+2366.2%
Q2 FY2020Jun 30, 2020€86.06M–
Q4 FY2019Dec 31, 2019€103.35M–
Q4 FY2018Dec 31, 2018€39.37M–
Q4 FY2017Dec 31, 2017€8.42M–

More Immatics figures

See a number that looks wrong?